The Indian Patent Office has recently issued a clarification on the Designs Act, 2000. The circular states that for registration of designs, one application would suffice for any one or all of the articles that are categorised under the same class, irrespective of the sub classes. For more information, please check out the circular in...

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced that the U.S. Patent and Trademark Office has issued to the Company patent 9,096,827 titled “Adherent Cells From Placenta Tissue and Use Thereof in Therapy”. The patent protects specific methods of culturing placental adherent stromal cells, and use of these cells for...

The United States Patent and Trademark Office (USPTO) has recently granted US Patent No. 9080184 entitled “Transgenic Therapeutic Stem Cells and Methods for Their Use and Manufacture” to Stemedica Cell Technologies Inc. This patent contains extra amount of human granulyotic colony thus offering neuroprotection as well as neurogenesis.

The company claims that the claimed water soluble fertilizer which being a clean technology addresses the concerns about the toxicity, safety and the environment issues facing the world and thus is a decent replacement to the synthetic fertilizers.

The FDA has approved the world’s first 3D printed drug for the treatment of epilepsy. The new drug, Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy. The 3D technology allows Spritam (levetiracetam) to have higher manufacturing precision thus accommodating a higher dose almost upto 1000 mg in each tablet. As...

Suven Life Sciences Ltd. from Hyderabad had announced the grant of one product patent from Mexico (No: 325948 and Title: Bicyclic compounds as ligands of the nicotinic receptor beta 2 acetylcholine alpha 4) and one product patent from Singapore (No: 180674 and Title: Bicyclic compounds as alpha-4-beta-2 nicotinic acetylcholine receptor ligands) that cover New Chemical...

Janssen Pharmaceuticals, a pharmaceutical company of Johnson & Johnson, has announced an expanded policy on improved accessibility of medicines in which the geographic scope of its earlier 2012 policy of waiving enforcement of patent rights for pediatric formulations of Darunavir, is expanded. This expansion includes many low and middle income countries including India, Pakistan and...

Indus Foundation, a registered non-profit trust for promoting healthcare in India is organizing three summits viz. Indo-Global Pharma Expo and Summit 2015, Indo-Global Medical Expo and Summit 2015 and Indo-Global Healthcare Expo and Summit 2015, from July 23 to July 26, 2015 at Hyderabad. Indus Foundation is organizing this summit in association with Federation of...

COEO Labs, a medical technology startup, based in Bangalore has filed patent application for protecting an automated tracheal secretion management device, VAPCare that is developed by the company. The medical device is designed to prevent ventilation associated pneumonia in patients under critical care.

In response to clubbing India with other countries in the “Priority watch list” of special 301 report released by USTR, the Commerce and Industry Minister, Nirmala Sitharaman stated that India will keep its national interest in mind while framing the new IPR policy and will not respond to outside pressure. She also stated that the...